Delivery Order SPE2DB22D1202-SPE2DB25FVFL1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $22,965.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- The Defense Logistics Agency awarded a $5,476.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete in open federal procurement processes for...
- The Defense Logistics Agency (DLA) awarded a $13,398.50 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $5,630.51 delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This firm fixed price contract, with an ultimate completion date of August 11, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was made on a competitive basis without any set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,836.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,863.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on July 17, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $12,870.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Defense Logistics Agency contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $7,058.85 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This non-set-aside, firm fixed-price contract is classified as a delivery order with a completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFL1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,831.93 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pens on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery order fulfillment for pharmaceutical supplies to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of medical product deliveries with the Defense Logistics Agency's Medical Supply Chain, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 7/23/25 |